225 related articles for article (PubMed ID: 24737272)
1. N-of-1 (single-patient) trials for statin-related myalgia.
Joy TR; Monjed A; Zou GY; Hegele RA; McDonald CG; Mahon JL
Ann Intern Med; 2014 Mar; 160(5):301-10. PubMed ID: 24737272
[TBL] [Abstract][Full Text] [Related]
2. Summaries for patients. Treatment trials to determine whether statins are the cause of a patient's discomfort.
Ann Intern Med; 2014 Mar; 160(5):I-34. PubMed ID: 24737270
[No Abstract] [Full Text] [Related]
3. N-of-1 (single-patient) trials for statin-related myalgia.
Joy TR; Zou GY; Mahon JL
Ann Intern Med; 2014 Oct; 161(7):531-2. PubMed ID: 25285548
[No Abstract] [Full Text] [Related]
4. N-of-1 (single-patient) trials for statin-related myalgia.
Akinboro O; Williams L; Pomerantz D
Ann Intern Med; 2014 Oct; 161(7):531. PubMed ID: 25285547
[No Abstract] [Full Text] [Related]
5. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
6. Statin, the black box.
Hatem S; Boccara F
Arch Cardiovasc Dis; 2008 Jun; 101(6):377-9. PubMed ID: 18809149
[No Abstract] [Full Text] [Related]
7. Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials.
Wlodarczyk J; Sullivan D; Smith M
Am J Cardiol; 2008 Dec; 102(12):1654-62. PubMed ID: 19064019
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial.
Schwartz GG; Bolognese MA; Tremblay BP; Caplan R; Hutchinson H; Raza A; Cressman M
Am Heart J; 2004 Jul; 148(1):e4. PubMed ID: 15215813
[TBL] [Abstract][Full Text] [Related]
9. Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?
Glueck CJ; Rawal B; Khan NA; Yeramaneni S; Goldenberg N; Wang P
Metabolism; 2009 Feb; 58(2):233-8. PubMed ID: 19154957
[TBL] [Abstract][Full Text] [Related]
10. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P
Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
[TBL] [Abstract][Full Text] [Related]
11. The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.
Fonseca FA; Ruiz A; Cardona-Muñoz EG; Silva JM; Fuenmayor N; Marotti M;
Curr Med Res Opin; 2005 Aug; 21(8):1307-15. PubMed ID: 16083541
[TBL] [Abstract][Full Text] [Related]
12. Strong statins as the major players for dyslipidemia in high-risk patients: are they all the same or not?
Ikewaki K; Ayaori M
Circ J; 2011; 75(6):1326-7. PubMed ID: 21532174
[No Abstract] [Full Text] [Related]
13. Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study.
Faergeman O; Hill L; Windler E; Wiklund O; Asmar R; Duffield E; Sosef F;
Cardiology; 2008; 111(4):219-28. PubMed ID: 18434729
[TBL] [Abstract][Full Text] [Related]
14. Giant cell arteritis and polymyalgia rheumatica after reexposure to a statin: a case report.
de Jong HJ; Meyboom RH; Helle MJ; Klungel OH; Niskanen L; Cohen Tervaert JW
Ann Intern Med; 2014 Oct; 161(8):614-5. PubMed ID: 25329212
[No Abstract] [Full Text] [Related]
15. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.
Farnier M; Averna M; Missault L; Vaverkova H; Viigimaa M; Massaad R; Vandormael K; Johnson-Levonas AO; Brudi P
Int J Clin Pract; 2009 Apr; 63(4):547-59. PubMed ID: 19222610
[TBL] [Abstract][Full Text] [Related]
16. Discontinuation of statin therapy due to muscular side effects: a survey in real life.
Rosenbaum D; Dallongeville J; Sabouret P; Bruckert E
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):871-5. PubMed ID: 22748604
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance.
Kennedy SP; Barnas GP; Schmidt MJ; Glisczinski MS; Paniagua AC
J Clin Lipidol; 2011; 5(4):308-15. PubMed ID: 21784377
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin for stroke prevention.
Med Lett Drugs Ther; 2006 Sep; 48(1243):75-6. PubMed ID: 16977287
[No Abstract] [Full Text] [Related]
19. Physiogenomic association of statin-related myalgia to serotonin receptors.
Ruaño G; Thompson PD; Windemuth A; Seip RL; Dande A; Sorokin A; Kocherla M; Smith A; Holford TR; Wu AH
Muscle Nerve; 2007 Sep; 36(3):329-35. PubMed ID: 17600820
[TBL] [Abstract][Full Text] [Related]
20. One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.
Ferdinand KC; Davidson MH; Kelly MT; Setze CM
Am J Cardiovasc Drugs; 2012 Apr; 12(2):117-25. PubMed ID: 22263674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
